Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients

Fig. 3

Kaplan-Meier survival curves comparing the high and low expression of SRGN in different types of cancer in TIMER database (a-l). BLCA,bladder urothelial carcinoma; BRCA, Breast invasive carcinoma; COAD, colon adenocarcinoma; KICH, kidney chromophobe; KIRC, kidney renal clear cell carcinoma; LIHC, liver hepatocellular carcinoma; LUAD, lung adenocarcinoma; LUSC, Lung squamous cell carcinoma; PRAD, prostate adenocarcinoma; READ, rectum adenocarcinoma; UCEC,uterine corpus endometrial carcinoma; SKCM, skin cutaneous melanoma; SRGN, serglycin

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us